Evidence map›Paper›PMID 39207816›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2024

Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology.

Rui Campante Teles, Eric Van Belle, Radoslaw Parma, Giuseppe Tarantini, Nicolas van Mieghem, Darren Mylotte, Joana Delgado Silva, Stephen O'Connor, Lars Sondegaard, Andre Luz and 48 more

Registry-linked trialAbstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07343674 (PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07343674 recruitingnot on this mapstarted 2026, after this paper: background citation

PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

Typeobservational_patient_registrySponsorPortuguese Association of Interventional CardiologyRan2026 to 2028Enrolled500ConditionsSevere Symptomatic Aortic Stenosis (Defined as New York Heart Association (NYHA) Class ≥ II)
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors.

Rui Campante TelesHospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Carnaxide and Comprehensive Health Research Center (CHRC), Nova Medical School, Lisbon, Portugal.
Eric Van BelleCHU Lille, Institut Coeur Poumon, Cardiologie, Université de Lille, France.
Radoslaw ParmaDepartment of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Giuseppe TarantiniInterventional Cardiology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Nicolas van MieghemErasmus Mc, Interventional Cardiology, Rotterdam, the Netherlands.
Darren MylotteDepartment of Cardiology, University Hospital and National University of Ireland, Galway, Ireland.
Joana Delgado SilvaCardiovascular Intervention Unit, Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.
Stephen O'ConnorSt James's Hospital, Cardiology Unit, Dublin, Ireland.
Lars SondegaardDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Andre LuzCentro Hospitalar Universitário do Porto, Porto, Portugal.
Ignacio Jesus Amat-SantosHospital Clinico Universitario, Cardiology Department, Valladolid, Spain.
Dabit ArzamendiHospital de la Santa Creu i Sant Pau, Cardiology Department, Barcelona, Spain.
Daniel BlackmanLeeds Teaching Hospitals, Leeds, United Kingdom.
Ole De BackerDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Vijay KunadianTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, United Kingdom and Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Gill Louise BuchananNorth Cumbria Integrated Care NHS Foundation Trust, Department of Cardiology Cumberland Infirmary, Carlisle, United Kingdom.
Phil MacCarthyKing's College Hospital, London, United Kingdom.
Philipp LurzDepartment of Cardiology, Universitätsmedizin Mainz, Mainz, Germany.
Christopher NaberFacharztpraxis Baldeney - Kardiologie und Innere Medizin, Essen, Germany.
Alaide ChieffoInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy, and Vita-Salute San Raffaele University, Milan, Italy.
Valeria ParadiesMaasstad Hospital, Rotterdam, the Netherlands.
Martine GilardCHU La Cavale Blanche, Department Of Cardiology, Brest, France.
Flavien VincentCHU Lille, Institut Coeur Poumon, Cardiologie, Université de Lille, France.
Chiara FraccaroInterventional Cardiology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Julinda MehilliDepartment of Cardiology, Pulmonology and Intensive Medicine, Hospital Landshut-Achdorf, Landshut, Germany.
Cristina GianniniSD Emodinamica, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Bruno SilvaCardiology Department, Hospital Central do Funchal, Madeira, Portugal.
Petra PoliacikovaCentral Slovakia Institute of Cardiovascular diseases, Banska Bystrica, Slovakia.
Nicole KaramEuropean Hospital Georges Pompidou, Cardiology Department, Paris, France.
Verena VeulemansUniversity Heart and Vascular Center Frankfurt, Germany.
Holger ThieleLeipzig Heart Centre, Internal Medicine/Cardiology, University of Leipzig, Leipzig, Germany.
Thomas PilgrimDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Marleen van WelyRadboud UMC, Department of Cardiology, Nijmegen, the Netherlands.
Stefan JamesDepartment of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Michael Rahbek SchmidtAdult Congenital Heart Disease Unit, Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Anselm UebingDepartment of Congenital and Paediatric Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Germany and German Centre for Cardiovascular Research, Partner Site Kiel, Kiel, Germany.
Andreas RückKarolinska University Hospital, Department of Cardiology, Stockholm, Sweden.
Alexander GhanemAsklepios Klinik Nord - Heidberg, Hamburg, Germany.
Ziyad GhazzalAmerican University of Beirut, Beirut, Lebanon.
Francis R JoshiDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Luca FaveroCardiovascular Department, Ca' Foncello Regional Hospital, Treviso, Italy.
Renicus HermanidesIsala Heart centre, Isala Hospital, Department of Cardiology, Zwolle, the Netherlands.
Vlasis NiniosCardiology Department, Interbalkan European Medical Center, Thessaloniki, Greece.
Luca Nai FovinoInterventional Cardiology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Rutger-Jan NuisErasmus Mc, Interventional Cardiology, Rotterdam, the Netherlands.
Pierre DeharoHopital de la Timone, Department of Cardiology, Marseille, France.
Petr KalaDepartment of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic and Department of Internal Medicine and Cardiology, Medical Faculty of Masaryk University, Brno, Czech Republic.
Gabby Elbaz-GreenerHadassah Medical Center, Hebrew University, Jerusalem, Israel.
Didier TchétchéClinique Pasteur, Groupe Cardiovasculaire Interventionnel, Toulouse, France.
Eustachio AgricolaCardiovascular Imaging Unit, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Matthias ThielmannDepartment of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.
Erwan DonalCardiology Department, Universite de Rennes-1, CHU de Rennes, Rennes, France.
Nikolaos BonarosDepartment of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Steven DroogmansUZ Brussel, Department of Cardiology, Jette, Belgium.
Martin CzernyClinic for Cardiovascular Surgery, University Heart Center Freiburg Bad Krozingen, Bad Krozingen, Germany and Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Andreas BaumbachCentre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London and Barts Heart Centre, London, United Kingdom.
Emanuele BarbatoDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Dariusz DudekInstitute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define competency levels required by newly trained SHD interventional cardiologists (IC) and provides guidance for training centres. SHD ICs are cardiologists who have received complete interventional cardiology training. They are multidisciplinary team specialists who manage adult SHD patients from diagnosis to follow-up and perform percutaneous procedures in this area. They are competent in interpreting advanced imaging techniques and master planning software. The SHD ICs are expected to be proficient in the aortic, mitral, and tricuspid areas. They may have selective skills in either the aortic area or mitral/tricuspid areas. In this case, they must still have common transversal competencies in the aortic, mitral, and tricuspid areas. Additional SHD domain competencies are optional. Completing dedicated SHD training, aiming for full aortic, mitral, and tricuspid competencies, requires at least 18 months. For full training in the aortic area, with basic competencies in mitral/tricuspid areas, the training can be reduced to 1 year. The same is true for training in the mitral/tricuspid area, with competencies in the aortic area. The SHD IC CC promotes excellence and homogeneous training across Europe and is the cornerstone of future certifications and patient protection. It may be a reference for future CC for national associations and other SHD specialities, including imaging and cardiac surgery.

Identifiers

PMID39207816
PMCPMC11556405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.